Timothy Newton

Timothy Newton is a seasoned founder and executive with a strong background in strategy, business development, and competitive intelligence within the biotechnology sector. They founded Reflection Therapeutics, where they developed a regulatory T cell therapy targeting neurodegeneration and raised over $1 million in funding. Previously, Timothy held leadership roles at AstraZeneca in Business Planning and Operations for Neuroscience. They have also contributed to the field as a postdoctoral research associate at the University of Cambridge and through various roles in research and venture building focused on neurodegenerative diseases. Timothy earned multiple degrees, including a Doctor of Philosophy in Medicine from the University of Cambridge and an MBiochem from the University of Oxford.